Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients

Journal of Diabetes Investigation

Volumn 5, Issue 2, 2014, Pages 192-198

  Foucan, Lydia ^a,b   Maimaitiming, Suliya ^c,d   Larifla, Laurent ^a,e   Hedreville, Segho ^e   Deloumeaux, Jacqueline ^a,b   Joannes, Marie Odile ^a   Blanchet Deverly, Anne ^a   Velayoudom Céphise, Fritz Line ^a   Aubert, Roberte ^c   Salamon, Roger ^c   Donnet, Jean Paul ^f   Fumeron, Frederic ^c,d  

^a Research Group Clinical Epidemiology and Medicine ECM LAMIA EA 4540 University Hospital of Guadeloupe University of Antilles and Guyane   (Guadeloupe)

^b Department of Medical Information and Public Health ^*  (Guadeloupe)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Cardiology Unit   (Guadeloupe)

^f University of Antilles and Guyane   (Guadeloupe)

Author keywords

Adiponectin; Cardiometabolic risk; Diabetes

Indexed keywords

ADIPONECTIN; ISOPROTEIN;

AD GENE; ADULT; AFRICAN CARIBBEAN; ALLELE; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIC WAIST; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84896493957     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12133     Document Type: Article

References (41)

1. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-949.
2. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003; 26: 2015-2020.
3. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89.
4. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730-1737.
5. Guerre-Millo M. Adiponectin: an update. Diabetes Metab 2008; 34: 12-18.
6. Ebinuma H, Miyazaki O, Yago H, et al. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta 2006; 372: 47-53.
7. Tonelli J, Li W, Kishore P, et al. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes. Diabetes 2004; 53: 1621-1629.
8. Bodles AM, Banga A, Rasouli N, et al. Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes. Am J Physiol Endocrinol Metab 2006; 291: E1100-E1105.
9. Kanaya AM, Wassel Fyr C, Vittinghoff E, et al. Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 2006; 91: 5044-5050.
10. Kizer JR, Barzilay JI, Kuller LH, et al. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008; 93: 3357-3364.
11. Lawlor DA, Davey Smith G, Ebrahim S, et al. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005; 90: 5677-5683.
12. Baessler A, Schlossbauer S, Stark K, et al. Adiponectin multimeric forms but not total adiponectin levels are associated with myocardial infarction in non-diabetic men. J Atheroscler Thromb 2011; 18: 616-627.
13. Foucan L, Ezourhi N, Maimaitiming S, et al. Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent. Obesity (Silver Spring) 2010; 18: 1466-1468.
14. Inoue T, Kotooka N, Morooka T, et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007; 100: 569-574.
15. Vionnet N, El Hani H, Dupont S, et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000; 67: 1470-1480.
16. Fumeron F, Aubert R, Siddiq A, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004; 53: 1150-1157.
17. Lara-Castro C, Doud EC, Tapia PC, et al. Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans. Obesity (Silver Spring) 2008; 16: 2616-2623.
18. Ukkola O, Santaniemi M, Rankinen T, et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann Med 2005; 37: 141-150.
19. Vasseur F, Helbecque N, Dina C, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-2614.
20. Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes. Mol Biol Rep 2011; 38: 3703-3708.
21. Bacci S, Menzaghi C, Ercolino T, et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004; 27: 2015-2020.
22. Chiodini BD, Specchia C, Gori F, et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis 2010; 4: 223-230.
23. Lacquemant C, Froguel P, Lobbens S, et al. The adiponectin gene SNP+45 is associated with coronary artery disease in type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 2004; 21: 776-781.
24. Zhang H, Mo X, Hao Y, et al. Association between polymorphisms in the adiponectin gene and cardiovascular disease: a meta-analysis. BMC Med Genet 2012; 13: 40.
25. Bostrom MA, Freedman BI, Langefeld CD, et al. Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes 2009; 58: 499-504.
26. Olckers A, Towers GW, van der Merwe A, et al. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007; 56: 587-592.
27. Kaser S, Tatarczyk T, Stadlmayr A, et al. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008; 38: 827-834.
28. Koenen TB, van Tits LJ, Holewijn S, et al. Adiponectin multimer distribution in patients with familial combined hyperlipidemia. Biochem Biophys Res Commun 2008; 376: 164-168.
29. Blackburn P, Lemieux I, Lamarche B, et al. Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women. Metabolism 2012; 61: 56-64.
30. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184.
31. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162.
32. Fujimoto WY, Boyko EJ, Hayashi T, et al. Risk factors for type 2 diabetes: lessons learned from Japanese Americans in Seattle. J Diabetes Invest 2012; B3: B212-B224.
33. Szmitko PE, Teoh H, Stewart DJ, et al. Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol 2007; 292: H1655-H1663.
34. Rizza S. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis 2009; 19: 54-60.
35. Retnakaran R, Hanley AJ, Connelly PW, et al. Low serum levels of high-molecular weight adiponectin in Indo-Asian women during pregnancy: evidence of ethnic variation in adiponectin isoform distribution. Diabetes Care 2006; 29: 1377-1379.
36. Delaigle AM, Jonas JC, Bauche IB, et al. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. Endocrinology 2004; 145: 5589-5597.
37. Ma H, Gomez V, Lu L, et al. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2009; 24: 233-237.
38. Qi L, Li T, Rimm E, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005; 54: 1607-1610.
39. An SS, Hanley AJ, Ziegler JT, et al. Association between ADIPOQ SNPs with plasma adiponectin and glucose homeostasis and adiposity phenotypes in the IRAS Family Study. Mol Genet Metab 2012; 107: 721-728.
40. Pineiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett 2005; 579: 5163-5169.
41. Shibata R, Sato K, Pimentel DR, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005; 11: 1096-1103.